1. NACP-IV components. [
http://www.naco.gov.in/nacp-iv-components
]. Accessed 5 Oct 2016.
2. NACP-IV Programme Priorities and Thrust Areas. [
http://www.naco.gov.in/programme-priorities-and-thrust-areas-0
]. Accessed 5 Oct 2016.
3. Allam RR, Murhekar MV, Bhatnagar T, Uthappa CK, Chava N, Rewari BB, Venkatesh S, Mehendale S. Survival probability and predictors of mortality and retention in care among patients enrolled for first-line antiretroviral therapy, Andhra Pradesh, India, 2008-2011. Trans R Soc Trop Med Hyg. 2014;108(4):198–205.
4. Bachani D, Garg R, Rewari BB, Hegg L, Rajasekaran S, Deshpande A, Emmanuel KV, Chan P, Rao KS. Two-year treatment outcomes of patients enrolled in India’s national first-line antiretroviral therapy programme. Natl Med J India. 2010;23(1):7–12.
5. Ghate M, Deshpande S, Tripathy S, Godbole S, Nene M, Thakar M, Risbud A, Bollinger R, Mehendale S. Mortality in HIV infected individuals in Pune, India. Indian J Med Res. 2011;133:414–20.